Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy. . PLoS One 2024;19:e0299822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy. PLoS One 2024;19:e0299822.
PMID: 38408063